Cantor Fitzgerald’s virtual panel on “Emerging Targets in Development for Inflammatory Bowel Disease (IBD)”

  • April 27, 2021 - April 27, 2021
  • Virtual panel discussion

We are delighted to participate in a virtual panel discussion on “Emerging Targets in Development for Inflammatory Bowel Disease (IBD)”, which will be hosted by Cantor Fitzgerald Equity Research on April 27 at 10:00AM ET.
Invited speakers from Biomica: Dr. Elran Haber , CEO and Dr. Shiri Meshner, VP R&D.

Back to all News

Highlighted News About Biomica

ASCO 2024 logo
Apr 16, 2024

American Society of Clinical Oncology (ASCO) 2024 Annual Meeting

We’re pleased to announce that Dr. Shiri Meshner, our VP of Research and Development, will be participating in the Pharmabiotic Conference 2024. She’ll be presenting alongside Claire Derlot, Chief Business Officer of Biose Industrie, on the topic “Biomica & Biose Industrie: The clinical journey of a multi-strain LBP”. Additionally, Dr. Meshner will contribute to a panel discussion focusing on Clinical Design & Methodology.